Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04829383 |
Title | A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma (AB7) |
Acronym | AB7 |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Kristen Spencer |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Illinois Cancer Center | Chicago | Illinois | 60612 | United States | Details | |
Indiana University Melvin and Bren Simon Comprehensive Cancer Center | Indianapolis | Indiana | 46202 | United States | Details | |
University of Nebraska Medical Center | Omaha | Nebraska | 68198 | United States | Details | |
Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | United States | Details | |
New York University Clinical Cancer Center | New York | New York | 10016 | United States | Details | |
DHR Health Institute for Research and Development | Edinburg | Texas | 785329 | United States | Details | |
Univeristy of Wisconsin | Madison | Wisconsin | 53705 | United States | Details |